Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

HIV Infection

Free Subscription 28.01.2019 5 AIDS 1 AIDS Res Hum Retroviruses 1 Am J Med 2 Antimicrob Agents Chemother 2 BMJ 1 Clin Infect Dis 1 HIV Med 7 J Acquir Immune Defic Syndr 2 J Immunol 2 J Infect Dis 7 J Virol 1 Lancet 1 Lancet Gastroenterol Hepatol 3 Lancet HIV 1 Lancet Infect Dis 2 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 1 Nature 2 Pediatrics 1 PLoS Med 19 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A 2 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. POMMIER JD, Laouenan C, Michard F, Papot E, et al
   Metabolic syndrome and endocrine status in HIV-infected transwomen.
   AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002152.
   PubMed     Text format     Abstract available
   
   
2. MILNE RS, Silverman RA, Beck IA, Mckernan-Mullin J, et al
   Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women.
   AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002134.
   PubMed     Text format     Abstract available
   
   
3. MONTOYA JL, Jankowski CM, O'Brien KK, Webel AR, et al
   Evidence-informed practical recommendations for increasing physical activity among persons living with HIV.
   AIDS. 2019 Jan 22. doi: 10.1097/QAD.0000000000002137.
   PubMed     Text format    
   
   
4. STUART RM, Haghparast-Bidgoli H, Panovska-Griffiths J, Grobicki L, et al
   Applying the 'no-one worse off' criterion to design Pareto efficient HIV responses in Sudan and Togo.
   AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002155.
   PubMed     Text format     Abstract available
   
   
5. WHELTON SP, Deal JA, Zikusoka M, Jacobson LP, et al
   Associations between lipids and subclinical coronary atherosclerosis.
   AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002151.
   PubMed     Text format     Abstract available
   
   

   
   AIDS Res Hum Retroviruses

6. HADDOW L, Sudre CH, Sokolska M, Gilson RC, et al
   Magnetic resonance imaging of cerebral small vessel disease in men living with HIV and HIV negative men aged 50 and above.
   AIDS Res Hum Retroviruses. 2019 Jan 22. doi: 10.1089/AID.2018.0249.
   PubMed     Text format     Abstract available
   
   

   
   Am J Med

7. SALAHUDDIN M, Karanth S, Ocazionez D, Estrada-Y-Martin RM, et al
   Clinical characteristics and etiologies of miliary nodules in the US; A single center study.
   Am J Med. 2019 Jan 16. pii: S0002-9343(19)30058.
   PubMed     Text format     Abstract available
   
   

   
   Antimicrob Agents Chemother

8. HIGASHI-KUWATA N, Hayashi S, Das D, Kohgo S, et al
   CMCdG, a novel nucleoside analog, exerts potent activity against wild-type and entecavir-resistant HBV with favorable safety feature.
   Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02143.
   PubMed     Text format     Abstract available
   
   
9. FRANCIS J, Zvada SP, Denti P, Hatherill M, et al
   Arylacetamide deacetylase (AADAC) gene polymorphism and HIV infection affect the exposure of Rifapentine: a population pharmacokinetics analysis.
   Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01964.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

10. TORJESEN I
    Some men who were unable to access PrEP through NHS trial are now HIV positive, charities report.
    BMJ. 2019;364:l299.
    PubMed     Text format    
    
    
11. TUMARKIN E, Siedner MJ, Bogoch II
    HIV pre-exposure prophylaxis (PrEP).
    BMJ. 2019;364:k4681.
    PubMed     Text format    
    
    

    
    Clin Infect Dis

12. MCMANUS M, Henderson J, Gautam A, Brody R, et al
    Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy.
    Clin Infect Dis. 2018 Sep 5. pii: 5090954. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    HIV Med

13. COLOMBA C, Saporito L, Gioe C, Tramuto F, et al
    Fatal measles as AIDS presentation in Italy.
    HIV Med. 2019 Jan 22. doi: 10.1111/hiv.12704.
    PubMed     Text format    
    
    

    
    J Acquir Immune Defic Syndr

14. BRAHMBHATT H, Santelli J, Kaagayi J, Lutalo T, et al
    Pregnancy Incidence and Fertility Desires Among Couples by HIV Status in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2019 Jan 17. doi: 10.1097/QAI.0000000000001951.
    PubMed     Text format     Abstract available
    
    
15. LONG J, Montano M, Cabello R, Sanchez H, et al
    Comparing sexual risk behavior in a high-risk group of men who have sex with men and transgender women in Lima, Peru.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001966.
    PubMed     Text format     Abstract available
    
    
16. BOATMAN JA, Baker JV, Emery S, Furrer H, et al
    Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001967.
    PubMed     Text format     Abstract available
    
    
17. TRAN NK, Hatzenbuehler ML, Goldstein ND
    Potential Relationship between HIV Criminalization and Structural Stigma Related to Sexual Orientation in the U.S.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001961.
    PubMed     Text format    
    
    
18. YU B, Pasipanodya E, Montoya JL, Moore RC, et al
    Metabolic Syndrome and Neurocognitive Deficits in HIV infection.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001964.
    PubMed     Text format     Abstract available
    
    
19. GANDHI M, Bacchetti P, SpinelliI MA, Okochi H, et al
    Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cut-Off for a Point-of-Care Test.
    J Acquir Immune Defic Syndr. 2019 Jan 11. doi: 10.1097/QAI.0000000000001971.
    PubMed     Text format     Abstract available
    
    
20. BERNAL E, Torres M, Alcaraz A, Alcaraz MJ, et al
    Association Between Erectile Dysfunction and Carotid Subclinical Atherosclerosis in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2018 Dec 4. doi: 10.1097/QAI.0000000000001932.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

21. LOGUE EC, Neff CP, Mack DG, Martin AK, et al
    Upregulation of Chitinase 1 in Alveolar Macrophages of HIV-Infected Smokers.
    J Immunol. 2019 Jan 21. pii: jimmunol.1801105. doi: 10.4049/jimmunol.1801105.
    PubMed     Text format     Abstract available
    
    
22. YEO KT, Embury P, Anderson T, Mungai P, et al
    HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.
    J Immunol. 2019 Jan 23. pii: jimmunol.1801024. doi: 10.4049/jimmunol.1801024.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

23. GISSLEN M, Hunt PW
    Antiretroviral treatment of acute HIV infection normalizes CSF markers of CNS inflammation. A consequence of reduced CNS reservoir?
    J Infect Dis. 2019 Jan 21. pii: 5298346. doi: 10.1093.
    PubMed     Text format    
    
    
24. HELLMUTH J, Slike BM, Sacdalan C, Best J, et al
    Very early ART initiation during acute HIV infection is associated with normalization of cerebrospinal fluid but not plasma markers of immune activation.
    J Infect Dis. 2019 Jan 21. pii: 5298345. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

25. TSO FY, West JT, Wood C
    Reduction of Kaposi's sarcoma-associated herpesvirus latency using CRISPR-Cas9 to edit the latency-associated nuclear antigen gene.
    J Virol. 2019 Jan 16. pii: JVI.02183-18. doi: 10.1128/JVI.02183.
    PubMed     Text format     Abstract available
    
    
26. BURTON S, Spicer LM, Charles TP, Gangadhara S, et al
    Clade C HIV-1 envelope vaccination regimens differ in their ability to elicit antibodies with moderate neutralization breadth against genetically diverse tier 2 HIV-1 envelope variants.
    J Virol. 2019 Jan 16. pii: JVI.01846-18. doi: 10.1128/JVI.01846.
    PubMed     Text format     Abstract available
    
    
27. LU W, Chen S, Yu J, Behrens R, et al
    The Polar Region of HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing gp120-gp41 Association.
    J Virol. 2019 Jan 16. pii: JVI.02128-18. doi: 10.1128/JVI.02128.
    PubMed     Text format     Abstract available
    
    
28. OJWACH DBA, MacMillan D, Reddy T, Novitsky V, et al
    Correction for Ojwach et al., "Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection".
    J Virol. 2019;93.
    PubMed     Text format    
    
    
29. ZOU C, Murakoshi H, Kuse N, Akahoshi T, et al
    Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    J Virol. 2019 Jan 23. pii: JVI.02142-18. doi: 10.1128/JVI.02142.
    PubMed     Text format     Abstract available
    
    
30. BRETON Y, Desrosiers V, Ouellet M, Deshiere A, et al
    Expression of MDM2 in macrophages promotes the early post-entry steps of HIV-1 infection through inhibition of p53.
    J Virol. 2019 Jan 23. pii: JVI.01871-18. doi: 10.1128/JVI.01871.
    PubMed     Text format     Abstract available
    
    
31. YU J, Liang C, Liu SL
    CD4-dependent Modulation of HIV-1 Entry by LY6E.
    J Virol. 2019 Jan 23. pii: JVI.01866-18. doi: 10.1128/JVI.01866.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

32. MICHAUD J, Moss K, Licina D, Waldman R, et al
    Militaries and global health: peace, conflict, and disaster response.
    Lancet. 2019;393:276-286.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

33. BOEREKAMPS A, De Weggheleire A, van den Berk GE, Lauw FN, et al
    Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.
    Lancet Gastroenterol Hepatol. 2019 Jan 16. pii: S2468-1253(18)30414.
    PubMed     Text format     Abstract available
    
    

    
    Lancet HIV

34. THIRUMURTHY H, Ndyabakira A, Marson K, Emperador D, et al
    Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
    Lancet HIV. 2019 Jan 16. pii: S2352-3018(18)30330.
    PubMed     Text format     Abstract available
    
    
35. RIVET AMICO K, Bekker LG
    Global PrEP roll-out: recommendations for programmatic success.
    Lancet HIV. 2019 Jan 16. pii: S2352-3018(19)30002.
    PubMed     Text format     Abstract available
    
    
36. BROWN B, Galea JT
    The effect of incentives on HIV research must be studied.
    Lancet HIV. 2019 Jan 16. pii: S2352-3018(18)30357.
    PubMed     Text format    
    
    

    
    Lancet Infect Dis

37. WHITWORTH HS, Badhan A, Boakye AA, Takwoingi Y, et al
    Clinical utility of existing and second-generation interferon-gamma release assays for diagnostic evaluation of tuberculosis: an observational cohort study.
    Lancet Infect Dis. 2019 Jan 14. pii: S1473-3099(18)30613.
    PubMed     Text format     Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

38. ABARA WE, Collier MG, Moorman A, Bixler D, et al
    Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:61-66.
    PubMed     Text format     Abstract available
    
    
39. JOHNS MM, Lowry R, Andrzejewski J, Barrios LC, et al
    Transgender Identity and Experiences of Violence Victimization, Substance Use, Suicide Risk, and Sexual Risk Behaviors Among High School Students - 19 States and Large Urban School Districts, 2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:67-71.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

40. 
    Facing Opioids in the Shadow of the HIV Epidemic.
    N Engl J Med. 2019;380:402.
    PubMed     Text format    
    
    

    
    Nature

41. BRINEY B, Inderbitzin A, Joyce C, Burton DR, et al
    Commonality despite exceptional diversity in the baseline human antibody repertoire.
    Nature. 2019 Jan 21. pii: 10.1038/s41586-019-0879.
    PubMed     Text format     Abstract available
    
    

    
    Pediatrics

42. SANTELLI JS, Klein JD, Song X, Heitel J, et al
    Discussion of Potentially Sensitive Topics With Young People.
    Pediatrics. 2019 Jan 16. pii: peds.2018-1403. doi: 10.1542/peds.2018-1403.
    PubMed     Text format     Abstract available
    
    
43. SPINNER C, Ding L, Bernstein DI, Brown DR, et al
    Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.
    Pediatrics. 2019 Jan 22. pii: peds.2018-1902. doi: 10.1542/peds.2018-1902.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

44. JONES J, Sullivan PS, Curran JW
    Progress in the HIV epidemic: Identifying goals and measuring success.
    PLoS Med. 2019;16:e1002729.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

45. ADEDIMEJI A, Sinayobye JD, Asiimwe-Kateera B, Chaudhry J, et al
    Social contexts as mediator of risk behaviors in Rwandan men who have sex with men (MSM): Implications for HIV and STI transmission.
    PLoS One. 2019;14:e0211099.
    PubMed     Text format     Abstract available
    
    
46. ELZOHARY L, Weglicki WB, Chmielinska JJ, Kramer JH, et al
    Mg-supplementation attenuated lipogenic and oxidative/nitrosative gene expression caused by Combination Antiretroviral Therapy (cART) in HIV-1-transgenic rats.
    PLoS One. 2019;14:e0210107.
    PubMed     Text format     Abstract available
    
    
47. 
    Retraction: PknE, a Serine/Threonine Protein Kinase of Mycobacterium tuberculosis Initiates Survival Crosstalk That Also Impacts HIV Coinfection.
    PLoS One. 2019;14:e0211247.
    PubMed     Text format    
    
    
48. MANE A, Sacks J, Sharma S, Singh H, et al
    Evaluation of five rapid diagnostic tests for detection of antibodies to hepatitis C virus (HCV): A step towards scale-up of HCV screening efforts in India.
    PLoS One. 2019;14:e0210556.
    PubMed     Text format     Abstract available
    
    
49. JABLONOWSKA E, Siwak E, Bociaga-Jasik M, Gasiorowski J, et al
    Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.
    PLoS One. 2019;14:e0210476.
    PubMed     Text format     Abstract available
    
    
50. PRICE J, Pettifor A, Selin A, Wagner RG, et al
    The association between perceived household educational support and HIV risk in young women in a rural South African community (HPTN 068): A cross sectional study.
    PLoS One. 2019;14:e0210632.
    PubMed     Text format     Abstract available
    
    
51. AMBERBIR A, Banda V, Singano V, Matengeni A, et al
    Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: A prospective cohort study.
    PLoS One. 2019;14:e0210629.
    PubMed     Text format     Abstract available
    
    
52. FU Y, Zorman B, Sumazin P, Sanna PP, et al
    Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats.
    PLoS One. 2019;14:e0203566.
    PubMed     Text format     Abstract available
    
    
53. DRAK D, Barratt H, Templeton DJ, O'Connor CC, et al
    Renal function and risk factors for renal disease for patients receiving HIV pre-exposure prophylaxis at an inner metropolitan health service.
    PLoS One. 2019;14:e0210106.
    PubMed     Text format     Abstract available
    
    
54. SHAMU S, Slabbert J, Guloba G, Blom D, et al
    Linkage to care of HIV positive clients in a community based HIV counselling and testing programme: A success story of non-governmental organisations in a South African district.
    PLoS One. 2019;14:e0210826.
    PubMed     Text format     Abstract available
    
    
55. SHAFII T, Benson SK, Morrison DM, Hughes JP, et al
    Results from e-KISS: electronic-KIOSK Intervention for Safer Sex: A pilot randomized controlled trial of an interactive computer-based intervention for sexual health in adolescents and young adults.
    PLoS One. 2019;14:e0209064.
    PubMed     Text format     Abstract available
    
    
56. CEULEMANS A, Bouzahzah C, Prat I, Urassa W, et al
    CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients: A laboratory performance evaluation of Muse Auto CD4/CD4% system by World Health Organization prequalification of in vitro diagnostics.
    PLoS One. 2019;14:e0209677.
    PubMed     Text format     Abstract available
    
    
57. DURTESTE M, Kyselyova G, Volokha A, Judd A, et al
    Anxiety symptoms and felt stigma among young people living with perinatally or behaviourally-acquired HIV in Ukraine: A cross-sectional survey.
    PLoS One. 2019;14:e0210412.
    PubMed     Text format     Abstract available
    
    
58. SONG X, Grilo SA, Mathur S, Lutalo T, et al
    Differential Impacts of HIV status on short-term fertility desires among couples in Rakai, Uganda.
    PLoS One. 2019;14:e0210935.
    PubMed     Text format     Abstract available
    
    
59. SABO MC, Balkus JE, Richardson BA, Srinivasan S, et al
    Association between vaginal washing and vaginal bacterial concentrations.
    PLoS One. 2019;14:e0210825.
    PubMed     Text format     Abstract available
    
    
60. BROWN LB, Getahun M, Ayieko J, Kwarisiima D, et al
    Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis.
    PLoS One. 2019;14:e0210126.
    PubMed     Text format     Abstract available
    
    
61. HILL AO, Bavinton BR, Armstrong G
    Prevalence and correlates of lifetime and recent HIV testing among men who have sex with men (MSM) who use mobile geo-social networking applications in Greater Tokyo.
    PLoS One. 2019;14:e0209933.
    PubMed     Text format     Abstract available
    
    
62. HANSEN SG, Womack J, Scholz I, Renner A, et al
    Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge.
    PLoS One. 2019;14:e0210252.
    PubMed     Text format     Abstract available
    
    
63. ROSE-CLARKE K, Bentley A, Marston C, Prost A, et al
    Peer-facilitated community-based interventions for adolescent health in low- and middle-income countries: A systematic review.
    PLoS One. 2019;14:e0210468.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Pathog

64. GRAYDON CG, Balasko AL, Fowke KR
    Roles, function and relevance of LAG3 in HIV infection.
    PLoS Pathog. 2019;15:e1007429.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

65. TAURA M, Song E, Ho YC, Iwasaki A, et al
    Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat.
    Proc Natl Acad Sci U S A. 2019 Jan 22. pii: 1819386116.
    PubMed     Text format     Abstract available
    
    

    
    Virology

66. LIU L, Li L, Nanfack A, Mayr LM, et al
    Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon.
    Virology. 2019;529:57-64.
    PubMed     Text format     Abstract available
    
    
67. KHAN AS, Bodem J, Buseyne F, Gessain A, et al
    Corrigendum to "Spumaretroviruses: Updated taxonomy and nomenclature" [Virology 516 (2018) 158-164].
    Virology. 2019 Jan 20. pii: S0042-6822(18)30390.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: